The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...
The DEA and HHS have postponed the implementation of the final rule on telemedicine prescribing of buprenorphine to Dec. 31.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback